{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:41:57Z","timestamp":1775043717952,"version":"3.50.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T00:00:00Z","timestamp":1294963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>To clarify the association of genetic producibility of interleukin (IL)-5, IL-6 and IL-13, which are secreted by T helper type 2 (Th2), with the development and prognosis of autoimmune thyroid disease (AITD), we genotyped IL5\u2212746C\/T, IL6\u2212572C\/G and IL13\u22121112C\/T polymorphisms, which are functional polymorphisms in the promoter regions of the genes regulating these cytokines. Fifty-seven patients with intractable Graves' disease (GD), 52 with GD in remission, 52 with severe Hashimoto's disease (HD), 56 with mild HD and 91 healthy controls were examined in this study. The IL13\u22121112T allele, which correlates with higher producibility of IL-13, was more frequent in patients with GD in remission than in those with intractable GD [P\u2003=\u20030\u00b7009, odds ratio (OR)\u2003=\u20033\u00b752]. The IL5\u2212746T allele, which may correlate with lower levels of IL-5, was more frequent in patients with GD in remission than controls (P\u2003=\u20030\u00b7029, OR\u2003=\u20032\u00b700). The IL6\u2212572G allele carriers (CG and GG genotypes), which have higher producibility of IL-6, were more frequent in AITD patients (P\u2003=\u20030\u00b7033, OR\u2003=\u20031\u00b775), especially in GD in remission (P\u2003=\u20030\u00b7031, OR\u2003=\u20032\u00b716) and severe HD (P\u2003=\u20030\u00b7031, OR\u2003=\u20032\u00b716) than in controls. Interestingly, both allele and genotype frequencies of Th2 cytokine genes were similar between GD and HD patients. In conclusion, functional polymorphisms in the genes encoding Th2 cytokines are associated differently with the development and prognosis of AITD from each other.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2010.04306.x","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T15:26:38Z","timestamp":1295018798000},"page":"318-323","source":"Crossref","is-referenced-by-count":48,"title":["Association of functional polymorphisms in promoter regions of<i>IL5, IL6<\/i>and<i>IL13<\/i>genes with development and prognosis of autoimmune thyroid diseases"],"prefix":"10.1093","volume":"163","author":[{"given":"N","family":"Inoue","sequence":"first","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Tatusmi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Hidaka","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Akamizu","sequence":"additional","affiliation":[{"name":"Translational Research Center, Kyoto University Hospital, Kyoto University School of Medicine, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Iwatani","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,1,14]]},"reference":[{"key":"2021122708482737800_b1","first-page":"1770","volume-title":"Principles and practice of endocrinology and metabolism","author":"Volpe","year":"2001"},{"key":"2021122708482737800_b2","first-page":"518","volume-title":"The thyroid \u2013 a fundamental and clinical text","author":"Davies","year":"2000"},{"key":"2021122708482737800_b3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2265.1976.tb02822.x","article-title":"Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid diseases","volume":"5","author":"Amino","year":"1976","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2021122708482737800_b4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1210\/jcem-46-6-859","article-title":"Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: studies of seventy autopsied cases","volume":"46","author":"Yoshida","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122708482737800_b5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1373\/clinchem.2007.099739","article-title":"The -590CC genotype in the IL4 gene as a strong predictive factor for the development of hypothyroidism in Hashimoto disease","volume":"54","author":"Nanba","year":"2008","journal-title":"Clin Chem"},{"key":"2021122708482737800_b6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1507\/endocrj.K06-015","article-title":"Association between the severity of Hashimoto's disease and the functional +874A\/T polymorphism in the interferon-\u03b3 gene","volume":"53","author":"Ito","year":"2006","journal-title":"Endocr J"},{"key":"2021122708482737800_b7","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.4049\/jimmunol.162.10.6178","article-title":"Th2-induced airway mucus production is dependent on IL-4R\u03b1, but not on eosinophils","volume":"162","author":"Cohn","year":"1999","journal-title":"J Immunol"},{"key":"2021122708482737800_b8","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.4049\/jimmunol.179.8.5367","article-title":"IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans","volume":"179","author":"Muller","year":"2007","journal-title":"J Immunol"},{"key":"2021122708482737800_b9","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.4049\/jimmunol.177.12.8633","article-title":"Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C&gt;T, a polymorphism associated with allergic inflammation","volume":"177","author":"Cameron","year":"2006","journal-title":"J Immunol"},{"key":"2021122708482737800_b10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1210\/jc.2004-0931","article-title":"Interleukin-13 gene polymorphisms confer the susceptibility of Japanese populations to Graves' disease","volume":"90","author":"Hiromatsu","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122708482737800_b11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1365-2265.2003.01880.x","article-title":"Interleukin-13 gene polymorphisms in patients with Graves' disease","volume":"59","author":"Bednarczuk","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2021122708482737800_b12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s10038-005-0297-x","article-title":"Association study between the IL4, IL13, IRF1 and UGRP1 genes in chromosomal 5q31 region and Chinese Graves' disease","volume":"50","author":"Yang","year":"2005","journal-title":"J Hum Genet"},{"key":"2021122708482737800_b13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1398-9995.2006.01300.x","article-title":"Polymorphisms in eosinophil pathway genes, asthma and atopy","volume":"62","author":"Kabesch","year":"2007","journal-title":"Allergy"},{"key":"2021122708482737800_b14","first-page":"1710","article-title":"Polymorphism of interleukins and interleukin receptor genes: population distribution and association with atopic bronchial asthma","volume":"38","author":"Freidin","year":"2002","journal-title":"Genetika"},{"key":"2021122708482737800_b15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0923-1811(03)00149-X","article-title":"Heterogeneity of interleukin 5 genetic background in atopic dermatitis patients: significant difference between those with blood eosinophilia and normal eosinophil levels","volume":"33","author":"Yamamoto","year":"2003","journal-title":"J Dermatol Sci"},{"key":"2021122708482737800_b16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/thy.1998.8.235","article-title":"Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis","volume":"8","author":"Hidaka","year":"1998","journal-title":"Thyroid"},{"key":"2021122708482737800_b17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/(SICI)1097-0320(19970615)30:3<118::AID-CYTO2>3.0.CO;2-H","article-title":"Analysis of IL-2 and IL-6 binding to peripheral blood lymphocytes in Graves disease: relationship with disease activity","volume":"30","author":"Corrales","year":"1997","journal-title":"Cytometry"},{"key":"2021122708482737800_b18","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1464-5491.2002.00844.x","article-title":"Interleukin-6 polymorphism (\u2212634C\/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes","volume":"19","author":"Kitamura","year":"2002","journal-title":"Diabet Med"},{"key":"2021122708482737800_b19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1089\/105072502760339370","article-title":"Independent involvement of CD8+CD25+ cells and thyroid autoantibodies in disease severity of Hashimoto's disease","volume":"12","author":"Watanabe","year":"2002","journal-title":"Thyroid"},{"key":"2021122708482737800_b20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1507\/endocrj.K07-005","article-title":"Ratio of serum IgG3 to total IgG concentration and goiter size are independent factors in intractability of Graves' disease","volume":"54","author":"Santoh","year":"2007","journal-title":"Endocr J"},{"key":"2021122708482737800_b21","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ni.1613","article-title":"A critical function for transforming growth factor-\u03b2 interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses","volume":"9","author":"Volpe","year":"2008","journal-title":"Nat Immunol"},{"key":"2021122708482737800_b22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/thy.2008.0423","article-title":"Increases of the Th1\/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease","volume":"19","author":"Nanba","year":"2009","journal-title":"Thyroid"},{"key":"2021122708482737800_b23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2249.2007.03575.x","article-title":"The +869T\/C polymorphism in the transforming growth factor-\u03b21 gene is associated with the severity and intractability of autoimmune thyroid disease","volume":"151","author":"Yamada","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"2021122708482737800_b24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2249.2009.04034.x","article-title":"Association of the \u221231C\/T functional polymorphism in the interleukin-1\u03b2 gene with the intractability of Graves' disease and the proportion of T helper type 17 cells","volume":"158","author":"Hayashi","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2021122708482737800_b25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1084\/jem.20061738","article-title":"IL-25 regulates Th17 function in autoimmune inflammation","volume":"204","author":"Kleinschek","year":"2007","journal-title":"J Exp Med"},{"key":"2021122708482737800_b26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/BF03346682","article-title":"Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9 and IL-13 with Graves' disease","volume":"33","author":"Zhu","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"2021122708482737800_b27","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.4049\/jimmunol.172.10.6020","article-title":"The role of IL-5 for mature B-1 cells in homeostatic proliferation, cell survival, and Ig production","volume":"172","author":"Moon","year":"2004","journal-title":"J Immunol"},{"key":"2021122708482737800_b28","first-page":"196","article-title":"Marked increase of CD5+ B cells in hyperthyroid Graves' disease","volume":"78","author":"Iwatani","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"2021122708482737800_b29","first-page":"1667","article-title":"Recurrence of thyrotoxicosis after attack of allergic rhinitis in patients with Graves' disease","volume":"77","author":"Hidaka","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122708482737800_b30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/jcla.20152","article-title":"Proinflammatory cytokine gene polymorphisms among Hashimoto's thyroiditis patients","volume":"20","author":"Chen","year":"2006","journal-title":"J Clin Lab Anal"},{"key":"2021122708482737800_b31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/1381612033391900","article-title":"Anti-interleukin-6 therapy for Crohn's disease","volume":"9","author":"Ito","year":"2003","journal-title":"Curr Pharm Des"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2010.04306.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/163\/3\/318\/41909361\/j.1365-2249.2010.04306.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/163\/3\/318\/41909361\/j.1365-2249.2010.04306.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T21:38:32Z","timestamp":1685914712000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/163\/3\/318\/6428889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,14]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,1,14]]},"published-print":{"date-parts":[[2011,2,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04306.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,3]]},"published":{"date-parts":[[2011,1,14]]}}}